Yahoo Web Search

Search results

  1. Aug 31, 2024 · ARKG is an actively managed ETF that invests in companies across multiple sectors related to genomics. See its net asset value, performance, holdings, fees, and fund documents.

  2. ARKG is an actively-managed ETF that invests in equity securities of companies across multiple sectors related to the genomics revolution. See its stock price, performance, holdings, sector weightings, news and related tickers.

  3. Jul 31, 2024 · ARKG is an ETF that invests in companies involved in genomic technologies and innovations. Morningstar assigns it a Negative rating based on its below-average process, people and parent pillars.

    • Morningstar Manager Research
  4. See the latest positions, trades, and weight of all companies in the ARKG ETF, managed by Cathie Wood. The fund invests in innovative genomics and biotechnology stocks across various categories and markets.

    Weight Rank
    Company
    Ticker
    Quote ($)
    8
    PRME
    $5.14
    9
    QSI
    $1.05
    10
    CMPS
    $6.04
    11
    REGN
    $1.05k
  5. Sep 12, 2024 · ARKG is an exchange-traded fund that tracks the performance of companies involved in genomics, DNA sequencing, bioinformatics and related fields. The fund has a net expense ratio of 0.75% and a market cap of $1.463 billion as of August 2024.

    • Health/Biotech
    • Open
    • October 31, 2014
    • Health/Biotech
  6. ARKG is an actively-managed ETF that invests in equity securities of companies across multiple sectors related to the genomics revolution. See its performance history, category comparison, and fund overview on Yahoo Finance.

  7. People also ask

  8. ARKG is an exchange-traded fund that invests in companies involved in genomic technologies and applications. Get the latest price, news, performance, and other data for ARKG and compare it with other ETFs and securities.

  1. People also search for